Company Name: |
TargetMol Chemicals Inc.
|
Tel: |
15002134094 |
Email: |
marketing@targetmol.cn |
Products Intro: |
Product Name:Lanopepden camsylate CAS:1441390-28-8 Package:100mg/RMB 25500;50mg/RMB 19800;25mg/RMB 15000
|
Cyclopentanepropanoic acid, α-[(formylhydroxyamino)methyl]-, (αR)-, 2-[5-fluoro-6-[(9aS)-hexahydropyrazino[2,1-c][1,4]oxazin-8(1H)-yl]-2-methyl-4-pyrimidinyl]hydrazide, 7,7-dimethyl-2-oxobicyclo[2.2.1]heptane-1-methanesulfonate (1:1) manufacturers
- Lanopepden camsylate
-
- $3700.00 / 100mg
-
2024-10-28
- CAS:1441390-28-8
- Min. Order:
- Purity:
- Supply Ability: 10g
|
| Cyclopentanepropanoic acid, α-[(formylhydroxyamino)methyl]-, (αR)-, 2-[5-fluoro-6-[(9aS)-hexahydropyrazino[2,1-c][1,4]oxazin-8(1H)-yl]-2-methyl-4-pyrimidinyl]hydrazide, 7,7-dimethyl-2-oxobicyclo[2.2.1]heptane-1-methanesulfonate (1:1) Basic information |
Product Name: | Cyclopentanepropanoic acid, α-[(formylhydroxyamino)methyl]-, (αR)-, 2-[5-fluoro-6-[(9aS)-hexahydropyrazino[2,1-c][1,4]oxazin-8(1H)-yl]-2-methyl-4-pyrimidinyl]hydrazide, 7,7-dimethyl-2-oxobicyclo[2.2.1]heptane-1-methanesulfonate (1:1) | Synonyms: | Cyclopentanepropanoic acid, α-[(formylhydroxyamino)methyl]-, (αR)-, 2-[5-fluoro-6-[(9aS)-hexahydropyrazino[2,1-c][1,4]oxazin-8(1H)-yl]-2-methyl-4-pyrimidinyl]hydrazide, 7,7-dimethyl-2-oxobicyclo[2.2.1]heptane-1-methanesulfonate (1:1);Lanopepden camsylate | CAS: | 1441390-28-8 | MF: | C32H50FN7O8S | MW: | 711.85 | EINECS: | | Product Categories: | | Mol File: | 1441390-28-8.mol | ![Cyclopentanepropanoic acid, α-[(formylhydroxyamino)methyl]-, (αR)-, 2-[5-fluoro-6-[(9aS)-hexahydropyrazino[2,1-c][1,4]oxazin-8(1H)-yl]-2-methyl-4-pyrimidinyl]hydrazide, 7,7-dimethyl-2-oxobicyclo[2.2.1]heptane-1-methanesulfonate (1:1) Structure](CAS/20211123/GIF/1441390-28-8.gif) |
| Cyclopentanepropanoic acid, α-[(formylhydroxyamino)methyl]-, (αR)-, 2-[5-fluoro-6-[(9aS)-hexahydropyrazino[2,1-c][1,4]oxazin-8(1H)-yl]-2-methyl-4-pyrimidinyl]hydrazide, 7,7-dimethyl-2-oxobicyclo[2.2.1]heptane-1-methanesulfonate (1:1) Chemical Properties |
| Cyclopentanepropanoic acid, α-[(formylhydroxyamino)methyl]-, (αR)-, 2-[5-fluoro-6-[(9aS)-hexahydropyrazino[2,1-c][1,4]oxazin-8(1H)-yl]-2-methyl-4-pyrimidinyl]hydrazide, 7,7-dimethyl-2-oxobicyclo[2.2.1]heptane-1-methanesulfonate (1:1) Usage And Synthesis |
Description | Lanopepden, also known as GSK-1322322 or GSK-322, is a potent and selective peptide deformylase inhibitor with good in vitro activity against bacteria associated with community-acquired pneumonia and skin infections. GSK1322322 had bactericidal activity against S. pneumoniae, H. influenzae, S. pyogenes, and S. aureus, demonstrating a ≥ 3-log(10) decrease in the number of CFU/ml at 4× MIC within 24 h in 29 of the 33 strains tested. GSK1322322 represents a valuable alternative therapy for the treatment of infectious diseases caused by drug-resistant pathogens. |
| Cyclopentanepropanoic acid, α-[(formylhydroxyamino)methyl]-, (αR)-, 2-[5-fluoro-6-[(9aS)-hexahydropyrazino[2,1-c][1,4]oxazin-8(1H)-yl]-2-methyl-4-pyrimidinyl]hydrazide, 7,7-dimethyl-2-oxobicyclo[2.2.1]heptane-1-methanesulfonate (1:1) Preparation Products And Raw materials |
|